Interventions for idiopathic intracranial hypertension.
CONCLUSIONS: Although the two included RCTs showed modest benefits for acetazolamide for some outcomes, there is insufficient evidence to recommend or reject the efficacy of this intervention, or any other treatments currently available, for treating people with IIH. Further high-quality RCTs are required in order to adequately assess the effect of acetazolamide therapy in people with IIH.
PMID: 26250102 [PubMed - as supplied by publisher]
Source: Cochrane Database of Systematic Reviews - Category: Journals (General) Authors: Piper RJ, Kalyvas AV, Young AM, Hughes MA, Jamjoom AA, Fouyas IP Tags: Cochrane Database Syst Rev Source Type: research
More News: Acetazolamide | Bariatric Surgery | Clinical Trials | Databases & Libraries | Diarrhoea | Eating Disorders & Weight Management | Eyes | General Medicine | Headache | Health | Hypertension | International Medicine & Public Health | Lumbar Puncture | Men | Migraine | Obesity | Study | Tinnitus | Weight Loss | WHO | Women